Distorted colour discrimination in Parkinson's disease is related to severity of the disease

Acta Neurologica Scandinavica

Volumn 96, Issue 5, 1997, Pages 293-296

  Muller Th ^a   Kuhn, W ^a   Buttner Th ^a   Przuntek, H ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Colour discrimination; Farnsworth Munsell 100 hue test; Parkinson's disease

Indexed keywords

DOPAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLOR DISCRIMINATION; COLOR VISION DEFECT; COLOR VISION TEST; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; MALE; PARKINSON DISEASE;

EID: 0030830758     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1997.tb00286.x     Document Type: Article

References (25)

1. BODIS WOLLNER I, TAGLIATI M. The visual system in Parkinson's disease. Adv Neurol 1993: 60: 390-4.
2. BODIS WOLLNER I, TAGLIATI M, PEPPE A, ANTAL A. Visual and visual perceptual disorders in neurodegenerative diseases. Baillieres Clin Neurol 1993: 2: 461-91.
3. BODIS-WOLLNER I, MARX MC, MITRA S, BOBACK P, MYLIN L, YAHR M. Visual dysfunction in Parkinson's disease: loss in spatial temporal contrast sensitivity in Parkinson's disease. Brain 1987: 11: 1675-98.
4. BÜTTNER T, KUHN W, KLOTZ P et al. Disturbance of colour perception in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1993: 6: 11-15.
5. BÜTTNER T, KUHN W, PRZUNTEK H. Alterations in chromatic contour perception in de novo parkinsonian patients. Eur Neurol 1995: 35: 226-9.
6. HAUG BA, KOLLE RU, TRENKWALDER C, OERTEL WH, PAULUS W. Predominant affection of the blue cone pathway in Parkinson's disease. Brain 1995: 118: 771-8.
7. HAUG BA, TRENKWALDER C, ARDEN GB, OERTEL WH, PAULUS W. Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease. Mov Disord 1994: 9: 563-70.
8. MUTHANE UB, SATISHCHANDRA P, SUBHASH MN. Visual and auditory evoked potentials in early onset Parkinson's disease and their relationship to cerebrospinal fluid monoamine metabolites. Mov Disord 1993: 8: 344-8.
9. PRICE MJ, FELDMAN RG, ADELBERG D, KAYNE H. Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 1992: 42: 887-90.
10. RASKIN SA, BOROD JC, WASSERSTEIN J, BODIS WOLLNER I, COSCIA L, YAHR MD. Visuospatial orientation in Parkinson's disease. Int J Neurosci 1990: 51: 9-18.
11. TODA K, TACHIBANA H, SUGITA M, KONISHI K. P300 and reaction time in Parkinson's disease. J Geriatr Psychiatry Neurol 1993: 6: 131-6.
12. TRICK GL, KASKIE B, STEINMAN SB. Visual impairment in Parkinson's disease: deficits in orientation and motion discrimination. Optom Vis Sci 1994: 71: 242-5.
13. BÜTTNER T, KUHN W, MÜLLER T, PATZOLD T, HEIDBRINK K, PRZUNTEK H. Distorted color discrimination in "de novo" parkinsonian patients. Neurology 1995: 45: 386-7.
14. BÜTTNER T, KUHN W, PATZOLD T, PRZUNTEK H. L-dopa improves colour vision in Parkinson's disease. J Neural Transm [P-D Sect] 1994: 7: 13-19.
15. BUTTNER T, KUHN W, MÜLLER T, MCMONAGLE U, PRZUNTEK H. Pharmacological effects of dopaminergics and amantadine on colour discrimination in Parkinson's disease. Neuroophthalmology 1995: 15: 135-41.
16. HUGHES AJ, LEES AJ, STERN GM. Challenge tests to predict the dopaminergic response in untreated Parkinson's disease. Neurology 1991: 41: 1723-5.
17. FARNSWORTH D. The Farnsworth-Munsell 100-hue and dichotomous test for color vision. J Opt Soc Am 1943: 33: 568-78.
18. KINNEAR PR. Proposals for scoring and assessing the 100-hue-test. Vision Res 1970: 10: 423-33.
19. SMITH V, POKORNY J, PASS A. Color-axis determination on the Farnsworth-Munsell 100-hue test. Am J Ophthalmol 1985: 100: 176-82.
20. VERRIEST G, VAN LAETHEM J, UVIJLS A. A new assessment of the normal ranges of the Farnsworth-Munsell 100-hue test scores. Am J Ophthalmol 1982: 93: 635-42.
21. MASSON G, MESTRE D, BLIN O. Dopaminergic modulation of visual sensitivity in man. Fundam Clin Pharmacol 1993: 7: 449-63.
22. HARNOIS C, DI PAOLO T. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 1990: 31: 2473-5.
23. BRAAK H, BRAAK E, YILMAZER D, DE; Vos RAI, JANSEN ENH. Nigral and extranigral pathology in Parkinson's disease. J Neural Transm Suppl 1995: 46: 15-32.
24. BRAAK H, BRAAK E, YILMAZER D, DE Vos RAI, JANSEN ENH, BOHL J. New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease. J Neural Transm Suppl 1996: 48: 1-6.
25. HERRERA AJ, MACHADO A, CANO J. Ageing and monoamine turnover in the lateral geniculate nucleus and visual cortex of the rat. Neurochem Int 1993: 22: 531-9.